Stonehouse Jon P
Visual SEC Form 4 history across 1 companies, 3 transactions and 2 filings.
Open-market buy performance
90-day forward return on this insider's open-market purchases
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Net value flow
Buys minus sells
Transaction texture
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
No latest transaction fact is available.
No open-market insider purchase is available.
No open-market insider sale is available.
Associated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| BCRX | Stonehouse Jon P | DIR | grant | 644 | $624k | A | — | 09/02 | 08/31 | |
| BCRX | Stonehouse Jon P | PRESCEO | gift | 10.0k | $0 | G | — | 01/04/2024 | 01/03/2024 | |
| BCRX | Stonehouse Jon P | PRESCEO | gift | 20.0k | $0 | G | — | 01/04/2024 | 01/03/2024 |
Stonehouse Jon P Insider Activity FAQ
SEC Form 4 context
Who is Stonehouse Jon P?
Stonehouse Jon P is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001385496.
Which companies has Stonehouse Jon P reported transactions for?
BIOCRYST PHARMACEUTICALS INC
When was Stonehouse Jon P's latest insider buy?
No open-market insider purchase is available for this period.
When was Stonehouse Jon P's latest insider sale?
No open-market insider sale is available for this period.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.